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Abstract: Three flavone-C-glycosides—cassiaoccidentalin A (1), isovitexin (2) and 
isoorientin (3)—were isolated from the ethyl acetate (EtOAc) soluble fraction of the 
methanol crude extract of the African medicinal plant Biophytum umbraculum, This is the 
first report of these compounds in this plant. All compounds were identified by 
spectroscopic analysis and comparison with published data. Isoorientin (3) and the EtOAc 
extract showed the greatest antioxidant activity in the DPPH assay as well as the strongest 
inhibition of xanthine oxidase (XO) and 15-lipoxygenase (15-LO). From these results, the 
extract of B. umbraculum might be a valuable source of flavone C-glycosides. 
Keywords: Biophytum umbraculum; flavone-C-glycosides; DPPH; xanthine oxidase;  
15-lipoxygenase 
 
1. Introduction 
Biophytum umbraculum Welw. (common syn. Biophytum petersianum Klotzsch) (Oxalidaceae) is a 
slender annual herb distributed in tropical and subtropical Africa, and across to Asia and New Guinea. 
The aerial parts of the plant have several medicinal uses in Mali and other African countries [1]. 
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Ethnopharmacological surveys on the use of B. umbraculum by practitioners in different districts in 
Mali (Bamako, Siby and Dioila) show that the plant is frequently used against cerebral malaria, but 
also against hemorrhoids, colonic ailments, wounds, stomach ache and fever [2–4]. In Nigeria the plant 
has been used against wounds, gonorrhea, urethral stones and stomach ache [1]. Other indications 
reported are constipation, hypertension, migraine, epilepsy, breathing difficulties and lack of  
fertility [1,5,6]. Various in vitro studies indicate that extracts of B. umbraculum may exert beneficial 
pharmaceutical effects on hypertension [5,7–10]. In addition, pectic polysaccharides isolated from B. 
umbraculum have demonstrated diverse effects on the immune system by virtue of complement 
fixation [3,4], activation of macrophages and dendritic cells [11], and modulation of intestinal Peyer’s 
patch cells [12]. Phytochemical investigations on B. umbraculum have so far been restricted to 
polysaccharides [3,4,11,12], although saponins of unknown structure have been stated to be present in 
aqueous extracts of the plant [13]. 
In the past decades, there has been a growing interest in antioxidants and free radical scavengers as 
they may have an important role in the prevention of pathologies in which reactive oxygen species 
(ROS) or free radicals are implicated, such as atherosclerosis, cardiovascular diseases (CVD), 
ischemia/reperfusion injury, neurodegenerative diseases and cancer [14,15]. As a part of an ongoing 
project on Malian medicinal plants [16–18], in the present study chemical characterization and 
investigation of antioxidant activity were performed on B. umbraculum. 
2. Results and Discussion 
2.1. Isolation and Structural Elucidation 
Compounds 1, 2 and 3 were isolated from the EtOAc soluble fraction of the MeOH crude extract of 
Biophytum umbraculum by column chromatography (CC).  Based on the weights of purified fractions, 
estimated concentrations of substances in the crude MeOH extract are 0.45% (1), 0.37% (2) and 0.17% (3). 
The compounds were identified as cassiaoccidentalin A (1), isovitexin (2) and isoorientin (3), 
respectively, by comparing their 1H-NMR and 13C-NMR spectroscopic data with those reported in the 
literature [19–21]. Besides, the COSY spectrum revealed 1H-1H couplings and helped assign proton 
resonances, especially those of the inner sugar of 1. The HSQC spectrum showed all 1J direct 1H-13C 
correlations and thus confirmed the assignments of all signals arising from the CH- and CH2- groups. 
Among all the 1H-13C long-range correlations observed in the HMBC spectrum, the most important 
were the correlations from the anomeric proton of the inner sugar (H-1′) to C-6 (2J), C-5 (3J) and C-7 (3J) 
of the aglycone, which confirmed the C-glycosylation at C-6. 
The chemical structures of the three flavone-C-glycosides are shown in Figure 1. To our 
knowledge, this is the first identification of flavone-C-glycosides in B. umbraculum. Compound 1 is a 
very rare flavone-C-glycoside which has only been identified once before, in Cassia occidentalis [19], 
whereas the more common flavone glucosides 2 and 3 have been identified in another Biophytum 
species, namely Biophytum sensitivum [22]. 
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Figure 1. Chemical structures of the three flavone-C-glycosides 1–3. 
 
2.2. Antioxidant Activity 
The dichloromethane (DCM) crude extract of B. umbraculum was virtually inactive as a DPPH 
radical scavenger, xanthine oxidase (XO) and 15-lipoxygenase (15-LO) inhibitor (IC50 > 167 µg/mL). 
The MeOH crude extract and the semi-polar extracts obtained by partitioning the MeOH extract 
showed fairly high radical scavenger activity and 15-LO inhibition (Table 1). The extracts showed 
moderate or low inhibitory activity towards XO compared to the positive control quercetin. The EtOAc 
extract exhibited the highest activity in all three assays. 
Table 1. DPPH radical scavenging, xanthine oxidase (XO) inhibition and 15-lipoxygenase 
(15-LO) inhibition of Biophytum umbraculum extracts. IC50 values ± SD (in µg/mL)  
are shown. 
Extract DPPH XO 15-LO 
DCM crude extract >167 >167 >167 
MeOH crude extract 13.4 ± 0.6 59.7 ± 6.1 68.9 ± 5.0 
EtOAc extract 6.8 ± 0.6 ca. 21 43.0 ± 3.6 
BuOH extract 12.5 ± 1.9 102.6 ± 5.6 53.4 ± 2.1 
Aqueous residue 29.8 ± 3.5 >167 >167 
Quercetin (positive control) 4.4 ± 0.4 2.33 ± 0.09 33.4 ± 0.3 
The activity of the isolated compounds as DPPH scavengers, XO- and 15-LO inhibitors is shown in 
Table 2. Flavone-C-glycosides were found to contribute both as DPPH scavengers and 15-LO 
inhibitors in the EtOAc extract. This is in good accordance with previous structure-activity studies 
indicating the importance of a 2,3 double bond in conjugation with a 4-oxo function in the C-ring and  
o-dihydroxy structure in the B-ring [23,24]. The strongest inhibitor of XO and 15-LO and the best 
DPPH scavenger was isoorientin. The strong DPPH radical scavenging activity of isoorientin and the 
much weaker activity of isovitexin are supported by previous results [25,26]. This antioxidant activity 
clearly shows that the 3′,4′-dihydroxy structural element of isoorientin is of importance for activity, 
isoorientin having an IC50 value similar to the positive control quercetin. This is in accordance with a 
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previous report [27]. The EtOAc extract may contain additional unidentified XO inhibitors, since XO 
inhibition of the isolated compounds does not account for the activity observed in the EtOAc extract. It 
has previously been suggested that flavones without a glycosyl group were relatively strong inhibitors 
of XO, as the presence of a glycosyl group would decrease the inhibitory activity [28,29]. XO and  
15-LO inhibitors may be beneficial for diseases and conditions such as ischemia/reperfusion, gout, 
renal stones, inflammation, arteriosclerosis, neurodegenerative diseases, cancer, aging, etc. [28,30–32]. 
Additionally, XO-inhibitors may have beneficial effects as adjuncts in the management of severe 
Plasmodium falciparum malaria [33]. 
Since the solubility in water of the flavonoids reported here is unknown (although a calculation, as 
given on the SciFinder website, gives theoretical values of between 0.12 and 0.15 mg/mL), an analysis 
of aqueous extracts of the plant may be relevant for the evaluation of its ethnopharmacological use, 
and might thus represent a useful continuation of the present work. 
These results imply that the extracts from B. umbraculum are a rich source of flavone-C-glycosides, 
and that herbal remedies obtained from this plant may have an effect against inflammations or other 
diseases related to oxidative stress. The results from our study would seem to be in accord with several 
of the reported ethnopharmacological usages of the plant. 
Table 2. Effects of isolated compounds from B. umbraculum on DPPH radical scavenging, 
xanthine oxidase (XO) inhibition and 15-lipoxygenase (15-LO) inhibition. IC50 values ± SD 
(in µM) are shown. 
Isolated compound DPPH XO 15-LO 
Cassiaoccidentalin A (1) >167 149.5 ± 7.4 99.9 ± 2.5 
Isovitexin (2) 96.0 ± 3.6 >167 107.1 ± 2.1 
Isoorientin (3) 18.1 ± 1.1 117.2 ± 13.5 86.4 ± 0.5 
Quercetin (positive control) 13.7 ± 1.3 7.7 ± 0.3 110.6 ± 1.0 
3. Experimental 
3.1. General 
1D and 2D NMR spectra were recorded on Bruker DPX 300 or Bruker AVII 400 instruments with 
CD3OD as solvent and TMS as internal standard. CC was done over Sephadex LH-20 (Pharmacia) or 
reverse phase (RP) silica (VersaPak C18 cartridges; Supelco). Fractions from CC were combined as 
indicated by TLC. Foils coated with Si gel RP-18 F254S (Merck) were used for analytical and 
preparative TLC. In analytical TLC, spots were visualized by UV irradiation (254 and 366 nm) and by 
spraying with Ce(SO4)2 (1% in 10% aqueous H2SO4) followed by heating (100 °C, 10–15 min). For 
UV/VIS measurements, a Biochrom Libra S32 PC instrument was employed. 
3.2. Plant Material 
Flowering, whole aerial parts of Biophytum umbraculum Welw. (Oxalidaceae) were collected in 
Blendio, Mali. The plant was identified by one of the authors, Prof. Drissa Diallo. A voucher specimen 
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(NO. 2653 DMT) was deposited in the herbarium at the Department of Traditional Medicine (DMT), 
Bamako, Mali. 
3.3. Extraction and Isolation 
The dried and powdered aerial parts of B. umbraculum (305 g) were extracted at RT with DCM  
(4 × 2.5 L), each time for 24 h, yielding 5.1 g of DCM extract (1.7% yield). The plant residue was then 
extracted similarly with MeOH (5 × 2.5 L) to yield 17.7 g (5.8%) of MeOH extract. The MeOH extract 
was suspended in 3 × 100 mL distilled water and successively partitioned with EtOAc (6 × 300 mL) 
and BuOH (5 × 200 mL). The solvents were removed under vacuum, affording an EtOAc extract  
(4.6 g), a BuOH extract (5.3 g) and an aqueous residue (5.0 g). The EtOAc (E) extract was 
chromatographed over Sephadex LH-20 (2.5 × 74 cm) with a gradient of H2O/MeOH (25%–100% 
MeOH) to yield 15 subfractions (E1-E15). E9 (334 mg), E10 (1,029 mg) and E11 (555 mg) were 
chosen for isolation of bioactive compounds based on fraction weights, pattern in NMR spectra and 
results from activity assays. E9 was flash chromatographed over RP C-18 Si gel (VersaPak, 2.3 × 11 cm) 
eluting with a H2O-MeOH gradient (40%–100% MeOH) to give 1 (57 mg). E10 was applied to a  
RP C-18 Si gel VersaPak column (4 × 15 cm) and eluted with a gradient of H2O-MeOH  
(20%–100% MeOH) to afford E10.1-E10.9. E10.6 (42 mg) and E10.7 (24 mg) were combined and 
rechromatographed over a smaller VersaPak column (2.3 × 11 cm) with a H2O-MeOH gradient  
(20%–100% MeOH) followed by preparative TLC to give 2 (8.8 mg). E11 was flash chromatographed 
with the same column as used for E10 and eluted with a gradient of H2O-MeOH (40%–100% MeOH) 
to yield E11.1-E11.13. E11.2 (50 mg) and E11.3 (21 mg) were combined and purified using the same 
system to give 3 (6.5 mg). A second batch of plant material (225 g) was subjected to Soxhlet extraction 
(2 L DCM for 48 h, followed by 3 L MeOH for 48 h). Yield of DCM extract was 7.5 g (3.3%), and of 
MeOH extract 17.2 g (7.6%). EtOAc extract (4.6 g), BuOH extract (3.3 g) and aqueous residue (5.1 g) 
were obtained similarly as above. 
3.4. DPPH Radical Scavenging 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [34]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.5. Inhibition of Xanthine Oxidase (XO) 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [35]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.6. Inhibition of 15-Lipoxygenase (15-LO) 
Pure substances and crude extracts (Soxhlet) were dissolved in DMSO, and the assay was carried 
out as reported previously [34]. Quercetin (Sigma-Aldrich) was used as positive control. 
3.7. Statistical Analysis 
All samples were analyzed in triplicates and the results are shown as mean ± standard deviation (SD). 
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4. Conclusions 
Our phytochemical study led to the isolation and characterization of three flavone-C-glycosides 
from the aerial parts of B. umbraculum. This is the first report on this type of compound from this 
plant. Compound 3 and the EtOAc extract of the plant revealed strong antioxidant activity towards 
DPPH radical and 15-LO, and moderate activity towards XO. Further studies on these extracts with 
respect to antioxidant properties in vivo are needed. 
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